Research Article
Isocratic High-Performance Liquid Chromatographic Assay of Olanzapine: Method Development and Validation
Table 2
Results of robustness study (OLP concentration, 10 μg mL−1).
| Chromatographic condition | Alteration | Peak area precision | Retention time precision | Mean area* ± SD | SE | RSD, % | Mean ± SD | SE | RSD, % |
| Mobile phase flow rate (mL min−1) | 0.9 | 606358 ± 0.0058 | 0.003 | 0.052 | 4.819 ± 0.004 | 0.023 | 0.073 | 1.0 | 547577 ± 0.000 | 0.000 | 0.000 | 4.364 ± 0.003 | 0.002 | 0.070 | 1.1 | 498323 ± 0.010 | 0.006 | 0.108 | 3.972 ± 0.002 | 0.002 | 0.038 |
| Column temperature (°C) | 38 | 546292 ± 0.025 | 0.014 | 0.249 | 4.399 ± 0.020 | 0.011 | 0.464 | 40 | 548214 ± 0.006 | 0.003 | 0.057 | 4.364 ± 0.001 | 0.006 | 0.023 | 42 | 548214 ± 0.020 | 0.012 | 0.198 | 3.972 ± 0.002 | 0.006 | 0.023 |
|
|
Mean value of three injections.
|